Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Integrated Stress Response (ISR) is a highly conserved intracellular signaling network that enables eukaryotic cells to adapt to various environmental and physiological stressors, such as endoplasmic reticulum (ER) stress, nutrient deprivation, and viral infection [1, 8]. The pathway is characterized by the convergence of four specialized kinases—PERK, PKR, GCN2, and HRI—which phosphorylate the alpha subunit of eukaryotic translation initiation factor 2 (eIF2α) [3, 7]. This phosphorylation event leads to a global reduction in protein synthesis to conserve energy and prevent the accumulation of misfolded proteins, while selectively enhancing the translation of stress-adaptive mRNAs like Activating Transcription Factor 4 (ATF4) [4, 15]. In the context of ER stress, the ISR overlaps significantly with the Unfolded Protein Response (UPR), utilizing sensors like IRE1 and ATF6 to restore proteostasis [14, 16]. While initially cytoprotective, chronic or excessive activation of the ISR can trigger apoptosis through the induction of CHOP, contributing to the pathogenesis of neurodegenerative diseases, diabetes, and cancer [10, 17]. Therapeutic modulation of the ISR is a burgeoning field, with small molecules like ISRIB (an eIF2B activator) and Sephin1 (a GADD34 inhibitor) showing promise in restoring cellular function or selectively inducing death in malignant cells [2, 5, 6].
Modulation of the ISR occurs through several mechanisms: eIF2B activation (e.g., ISRIB) to bypass eIF2alpha phosphorylation; inhibition of eIF2alpha kinases like PERK or IRE1; inhibition of the GADD34/PP1 phosphatase complex (e.g., Sephin1) to prolong the adaptive phase; and direct activation of stress kinases (e.g., ONC201) to induce apoptosis in cancer cells.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrated Stress Response (ISR) (ISR).